Adderall Dosage and Administration Guidelines

Introduction to Adderall Dosage

The American Academy of Child and Adolescent Psychiatry recommends starting Adderall immediate-release (IR) at 5 mg twice daily in adults or 2.5-5 mg daily in children, titrating by 5 mg weekly increments to a maximum of 40-50 mg per day; for extended-release (XR), start at 10 mg once daily in the morning and titrate by 5 mg weekly to the same maximum 1, 2

Adults and children ≥6 years should begin with 5 mg twice daily (after breakfast and lunch) 1
All ages should start with 10 mg once daily in the morning for the XR formulation 1, 2
Morning administration is critical to minimize sleep disturbances 1, 3

Increase the dose in 5 mg increments weekly for both IR and XR formulations, allowing at least one week between adjustments to properly evaluate response 1, 2
For IR, increase by 5 mg per dose (total daily increase of 10 mg if taking twice daily) 1
For XR, increase by 5 mg once weekly 1, 2
Weekly telephone contact is acceptable during initial titration, with in-person visits at least monthly until symptoms stabilize 1

The maximum recommended daily dose is 40-50 mg for both IR and XR formulations 1, 2
Recent American Academy of Child and Adolescent Psychiatry guidelines support up to 50 mg daily 1, 2
For children weighing <25 kg, single doses should not exceed 10 mg 1

Baseline assessment should include blood pressure and pulse 1, 3
Baseline assessment should include height and weight 1
At each visit, weight assessment to detect appetite suppression 1, 3
Quarterly for adults, blood pressure and pulse checks 2, 3
Systematic evaluation of target ADHD symptoms and side effects (insomnia, anorexia, headaches, social withdrawal, tics, weight loss) 1

Older adults are more sensitive to both therapeutic and adverse effects due to age-related pharmacokinetic changes 1, 3
Consider more conservative titration for older adults: increase by 5 mg every 2 weeks instead of weekly 1
Older adults may require starting dose of 2.5 mg (achieved by cutting a 5 mg IR tablet) 2
Pregnant women require careful risk-benefit analysis for treatment decisions, with a maximum dose of 50 mg 2
Discontinuing treatment in pregnant women can lead to worse mental health outcomes and functional impairment 4
Untreated ADHD in pregnant women is associated with increased risks for spontaneous abortion and preterm birth 4

Starting too high leads to unnecessary side effects and decreased adherence 1, 3
Inadequate time between dose increases must be avoided, allowing one full week to evaluate response 1
Exceeding maximum dose when ineffective: if 40-50 mg provides no benefit, switch medications rather than increasing further 1, 2
Failing to monitor systematically: both benefits and side effects must be assessed at each dose adjustment 1

If the maximum recommended dose (40-50 mg) does not provide adequate symptom control, do not increase further—instead, switch to an alternative stimulant or consider non-stimulant medications 1, 2
More medication is not necessarily better beyond the maximum dose 2
Reevaluate the diagnosis and assess for comorbid conditions affecting treatment response 1
Consider adding environmental or psychosocial interventions 1

IR tablets can be safely cut for dose titration when finding the optimal therapeutic dose 2